Background
Methods
Surgical methods
Surgical treatment of benign clavicular tumors
Surgical treatment of clavicular malignancy
Follow-up and statistical analysis
Follow-up
Statistical analysis
Results
The survival condition of patients with clavicular tumors
Patient | Gender/age (years) | Pathological diagnosis | Tumor location | Tumor size (cm) | Treatment | Follow-up (months) | Recurrence/metastasis | Result |
---|---|---|---|---|---|---|---|---|
Benign tumors | ||||||||
1 | F/8 | Osteochondroma | Medial 1/3 (right) | 2.5 × 2.5 | Intracapsular resection | 64 | No/no | Survival |
2 | F/17 | Osteochondroma | Lateral (left) | 2.0 × 1.0 | Intracapsular resection | 35 | No/no | Survival |
3 | F/29 | Osteochondroma | Medial (left) | 1.8 × 2.5 | Intracapsular resection | 12 | No/no | Survival |
4 | M/9 | Osteochondroma | Medial 1/3 (left) | 2.0 × 3.0 | Intracapsular resection | 24 | No/no | Survival |
5 | M/5 | Simple bone cysts | Medial (left) | 2.3 × 1.0 | Intracapsular resection | 71 | No/no | Survival |
6 | F/12 | Simple bone cysts | Medial 1/3 (right) | 2.0 × 1.5 | Intracapsular resection | 57 | No/no | Survival |
7 | M/15 | Ossifying fibroids | Middle (right) | 3.2 × 2.5 | Intracapsular resection | 30 | No/no | Survival |
8 | M/10 | Ossifying fibroids | Middle (right) | 4.5 × 3.0 | Intracapsular resection | 57 | No/no | Survival |
9 | M/34 | Spindle cell mesenchymal tumor | Medial (left) | 5.0 × 4.0 | Intracapsular resection | 57 | No/no | Survival |
Malignant tumors—non-construction group | ||||||||
10 | M/45 | Plasmacytoma | Medial (right) | 5.5 × 3.7 | Tumor resection | 23 | No/no | Survival |
11 | M/43 | Osteosarcoma | Medial 1/3 (right) | 10.5 × 10.0 | Tumor resection + radiotherapy | 19 | No/yes | Survival |
12 | M/53 | Ewing sarcoma | Middle (right) | 6.5 × 4.8 | Tumor resection + radiotherapy | 47 | No/no | Survival |
13 | M/46 | Metastatic cancer | Medial 1/3 (left) | 7.0 × 6.8 | Tumor resection + chemotherapy | 23 | No/no | Death |
14 | F/50 | Metastatic cancer | Medial 1/3 (right) | 7.5 × 6.0 | Tumor resection | 17 | No/no | Survival |
15 | F/40 | Ewing sarcoma | Lateral (left) | 6.0 × 4.5 | Tumor resection + radiotherapy | 38 | No/no | Survival |
Malignant tumors—reconstruction group | ||||||||
16 | M/49 | Plasmacytoma | Medial (left) | 5.7 × 3.0 | Tumor resection + plate-cement complex | 23 | Yes/no | Survival |
17 | F/42 | Osteosarcoma | Medial (right) | 5.5 × 5.0 | Tumor resection + plate-cement complex | 21 | No/no | Survival |
18 | M/46 | Synovial sarcoma | Medial (right) | 5.5 × 4.5 | Tumor resection + plate-cement complex | 23 | Yes/yes | Death |
19 | F/56 | Plasmacytoma | Lateral (right) | 4.8 × 1.9 | Tumor resection + plate-cement complex + chemotherapy | 18 | No/yes | Survival |
20 | M/55 | Metastatic cancer | Lateral (left) | 4.5 × 2.5 | Tumor resection + plate-cement complex | 15 | No/no | Death |
Benign clavicular tumors
Group/number | MSTS (%) | ASES | Constant-Murley score |
---|---|---|---|
Preoperation/9 | 59.63 ± 5.88 | 46.11 ± 3.69 | 49.67 ± 7.58 |
Postoperation/9 | 85.56 ± 4.71 | 89.89 ± 3.69 | 80.56 ± 5.10 |
P
| < 0.001 | 0.007 | < 0.001 |
Clavicular malignancy
Groups/number | MSTS | ASES | Constant-Murley score | ||||||
---|---|---|---|---|---|---|---|---|---|
Preoperative (%) | Postoperative (%) |
P
| Preoperative | Postoperative |
P
| Preoperative | Postoperative |
P
| |
Reconstruction/5 | 59.33 ± 3.65 | 86.00 ± 5.96 | 0.043 | 46.60 ± 7.83 | 91.60 ± 3.13 | 0.043 | 49.00 ± 6.16 | 81.00 ± 3.39 | < 0.001 |
Non-reconstruction/6 | 58.89 ± 2.72 | 86.11 ± 4.91 | < 0.001 | 43.00 ± 6.26 | 87.17 ± 5.27 | < 0.001 | 45.17 ± 6.11 | 79.67 ± 3.08 | < 0.001 |
P
| 0.822 | 0.974 | 0.418 | 0.134 | 0.331 | 0.511 |